Rocket Pharmaceuticals (RCKT) Intangibles (2022 - 2026)

Rocket Pharmaceuticals (RCKT) has 5 years of Intangibles data on file, last reported at $25.2 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles changed 0.0% year-over-year to $25.2 million; the trailing twelve-month figure through Mar 2026 stood at $25.2 million (changed 0.0% YoY), and the FY2025 full-year result was $25.2 million, changed 0.0% from the prior year.
• Intangibles steadied at $25.2 million in Q1 2026, from $25.2 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $25.7 million in Q4 2022 to a low of $25.2 million in Q3 2023.
• A 5-year average of $25.3 million and a median of $25.2 million in 2023 frame the typical range for Intangibles.
• Across the five-year window, Intangibles decreased 2.23% in 2023 and changed 0.0% in 2024, its largest moves.
• Tracing RCKT's Intangibles over 5 years: stood at $25.7 million in 2022, then slipped by 2.23% to $25.2 million in 2023, then changed by 0.0% to $25.2 million in 2024, then changed by 0.0% to $25.2 million in 2025, then changed by 0.0% to $25.2 million in 2026.
• Business Quant data shows RCKT's Intangibles at $25.2 million in Q1 2026, $25.2 million in Q4 2025, and $25.2 million in Q3 2025.